Abpro Holdings Files Definitive Additional Proxy Materials
Ticker: ABPWW · Form: DEFA14A · Filed: Oct 6, 2025 · CIK: 1893219
Sentiment: neutral
Topics: proxy-statement, corporate-governance, filing-update
TL;DR
Abpro Holdings filed proxy docs, standard shareholder meeting stuff. No fee.
AI Summary
Abpro Holdings, Inc. filed definitive additional materials on October 6, 2025, related to its proxy statement for the annual meeting of stockholders. The company, formerly known as Atlantic Coastal Acquisition Corp. II, is a biotechnology firm focused on biological products. This filing does not require a fee.
Why It Matters
This filing indicates that Abpro Holdings is proceeding with its annual shareholder meeting, which is a standard corporate governance process. Investors should review these materials for any updates or specific proposals being presented.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not present immediate financial or operational risks.
Key Players & Entities
- Abpro Holdings, Inc. (company) — Registrant
- Atlantic Coastal Acquisition Corp. II (company) — Former company name
- October 6, 2025 (date) — Filing date
FAQ
What type of filing is this?
This is a Definitive Additional Materials filing (DEFA14A) for Abpro Holdings, Inc.
When was this filing made?
The filing was made on October 6, 2025.
What is the company's primary business?
Abpro Holdings, Inc. is involved in Biological Products (No Diagnostic Substances).
Was there a fee associated with this filing?
No fee was required for this filing.
What was the company's former name?
The company was formerly known as Atlantic Coastal Acquisition Corp. II.
Filing Stats: 4,735 words · 19 min read · ~16 pages · Grade level 14.8 · Accepted 2025-10-06 16:15:01
Key Financial Figures
- $1.00 — ties to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price
- $1.00 m — y not exceed or remain in excess of the $1.00 minimum bid price for a sustained period
- $1.73 — at a weighted average exercise price of $1.73 per share; 242,400 shares of common s
- $0.32 — at a weighted average exercise price of $0.32 per share; 533,229 shares issuable up
- $3.33 — to Ian Chan with the exercise price of $3.33 per share. Unless otherwise indicated
- $0.0001 — common stock would remain unchanged at $0.0001 per share after the Reverse Stock Split
Filing Documents
- ea0260339-defa14a_abpro.htm (DEFA14A) — 81KB
- image_001.jpg (GRAPHIC) — 7KB
- image_002.jpg (GRAPHIC) — 391KB
- image_003.jpg (GRAPHIC) — 416KB
- 0001213900-25-096542.txt ( ) — 1203KB
From the Filing
ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement. Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). Definitive Proxy Statement. Definitive Additional Materials. Soliciting Material under § 240.14a-12. Abpro Holdings, Inc. (Name of Registrant as Specified in its Charter) N/A (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Amendment to Proxy Statement for Annual Meeting of Stockholders to be held October 10, 2025 This proxy statement amendment (this “Amendment”), dated October 6, 2025, updates and amends the definitive proxy statement on Schedule 14A (the “Proxy Securities and Exchange Commission (the “SEC”) on September 8, 2025, in connection with the solicitation by the Company’s Board of Directors (the “Board”), of proxies to be voted at the 2025 Annual Meeting of Stockholders, or any adjournment or postponement thereof (the “Annual Meeting”). This Amendment supplements and amends the Proxy Statement for the Annual Meeting to amend Proposal No. 3 as described more fully herein. This Amendment is being made available to shareholders beginning on or about October 6, 2025. Except as amended or superseded, all information set forth in the Proxy Statement remains unchanged and is important for you to review and consider before voting. In order to comply with Nasdaq listing requirements and avoid delisting, Proposal 3 is being amended to authorize our management to effect a reverse stock split of our issued and outstanding shares of common stock at a specific ratio of one-for-thirty (the “Reverse Stock Split”). This Reverse Stock Split, if effected, will be authorized by an amendment to our Certificate of Incorporation. The revised stockholder resolution for Amended Proposal 3 is set forth under the heading “Amended Proposal 3: Approval of Reverse Stock Split” on page 2 of this Amendment. This Amendment, our Proxy 2024 (including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024), and related information prepared in connection with the Annual Meeting are available at https://www.cstproxy.com/abpro/am2025. You will need the 12-digit control number included on your notice or proxy card in order to access the proxy materials. These proxy materials will be available free of charge. From and after the date of this Amendment, all references to the “Proxy Statement” are to the Proxy Statement as amended hereby. The Proxy If you have already returned your proxy card or voting instruction form, your votes on Proposal 1 and Proposal 2 remain valid and will be voted at the Annual Meeting. However, because the terms of Proposal 3 have been materially changed from a 1-for-10 ratio to a 1-for-30 ratio, any prior vote you submitted on Proposal 3 is no longer valid. To vote on the revised Proposal 3, or if you wish to change or revoke your vote on any proposal, you must submit a new proxy card or voting instruction form. Please refer to the disclosure in the Proxy Statement under “Questions and Answers About the Annual Meeting - Can I change my vote after submitting my proxy?,” on page 40 of the Proxy Statement for instructions on how to do so. AMENDED PROPOSAL 3 APPROVAL OF REVERSE STOCK SPLIT Overview Our Board has determined that it is advisable and in the best interests of the Company and its stockholders, for us to amend our Certificate of Incorporation to authorize our management to effect a reverse stock split (the “Reverse Stock Split Charter Amendment”) of our issued and outstanding shares of our common stock at a specific ratio of one-for-thirty (the “Split Ratio” and such reverse stock split at the Split Ratio, the “Reverse Stock Split”). A vote for this Amended Proposal 3 will constitute approval of the Reverse Stock Split that, once authorized by management and effected by filing the Reverse Stock Split Charter Amendment with the Secretary of State of the State of Delaware, will combine 30 shares of our common stock into one share of our common stock. If implemented, the Reverse Stock Split will have the effect of decreasing the number of shares of our common stock issued and outstanding. As used herein, “management” means the Company’s Chief Executive Officer. Accordingly, stockholders are asked to adopt and approve the Reverse Stock Split Cha